The United States announced that it has sent 2 million doses of the anti-malaria drug touted as a coronavirus treatment by President Donald Trump to Brazil.
In a joint statement Sunday, the U.S. and Brazil said the hydroxychloroquine will be used as a prophylactic to defend health care workers in Brazil against the virus, as well as a treatment to help Brazilians who become infected.
The U.S. is also sending 1,000 ventilators to Brazil, which has the second most cases of COVID-19 in the world. Globally, health officials report more than 6.18 million cases of the coronavirus and more than 372,460 deaths.
The U.S. leads the world in cases, with more than 1.79 million, and deaths, with more than 104,380. Brazil has more than 514,850 cases and 29,314 deaths.
Cartoons on the Coronavirus
A study published in The Lancet last month found that coronavirus patients given hydroxychloroquine actually had an increased risk of death and abnormal heart rhythms. However, that study has faced scrutiny. Brazilian President Jair Bolsonaro, a close ally of Trump, has also promoted hydroxychloroquine as a treatment for COVID-19.
The countries announced that they will launch a joint research effort that will include randomized controlled clinical trials to “help further evaluate the safety and efficacy of HCQ for both prophylaxis and the early treatment of the coronavirus.”
A small study of the drug conducted in Brazil was halted because of the risk of fatal heart complications, while the U.S. began its own clinical trial in April.
The statement said Trump and Bolsonaro have spoken twice since March and the countries are “well positioned to continue their work together.”